Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Callagy

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Oncologist|June 28, 2011
TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancerRonan W Glynn, Sarah Mahon, Catherine Curran, et al.
European Heart Journal|April 22, 2008
Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of IrelandRobert Byrne, Orla Constant, Yvonne Smyth, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
Molecular classification of breast carcinomas using tissue microarraysGrace Callagy, Elena Cattaneo, Yataro Daigo, et al.
Plos One|January 4, 2014
Prognostic significance of deregulated dicer expression in breast cancerEmer Caffrey, Helen Ingoldsby, Deirdre Wall, et al.
Virchows Archiv : an International Journal of Pathology|January 19, 2022
Incorporation of TILs in daily breast cancer care: how much evidence can we bear?Anne-Vibeke Laenkholm, Grace Callagy, Marcelo Balancin, et al.
Research Square|August 30, 2023
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerTimothy B Fisher, Geetanjali Saini, Rekha Ts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
Breast Cancer Research : BCR|January 18, 2024
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerTimothy B Fisher, Geetanjali Saini, T S Rekha, et al.
The Journal of Pathology|September 18, 2004
Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progressionMichael A Gonzalez, Kiku-E K Tachibana, Suet-Feung Chin, et al.
Oncotarget|November 9, 2017
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathwaysPablo Garrido, Aliaa Shalaby, Elaine M Walsh, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Oncologist|June 28, 2011
TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancerRonan W Glynn, Sarah Mahon, Catherine Curran, et al.
European Heart Journal|April 22, 2008
Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of IrelandRobert Byrne, Orla Constant, Yvonne Smyth, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
Molecular classification of breast carcinomas using tissue microarraysGrace Callagy, Elena Cattaneo, Yataro Daigo, et al.
Plos One|January 4, 2014
Prognostic significance of deregulated dicer expression in breast cancerEmer Caffrey, Helen Ingoldsby, Deirdre Wall, et al.
Virchows Archiv : an International Journal of Pathology|January 19, 2022
Incorporation of TILs in daily breast cancer care: how much evidence can we bear?Anne-Vibeke Laenkholm, Grace Callagy, Marcelo Balancin, et al.
Research Square|August 30, 2023
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerTimothy B Fisher, Geetanjali Saini, Rekha Ts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
Breast Cancer Research : BCR|January 18, 2024
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerTimothy B Fisher, Geetanjali Saini, T S Rekha, et al.
The Journal of Pathology|September 18, 2004
Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progressionMichael A Gonzalez, Kiku-E K Tachibana, Suet-Feung Chin, et al.
Oncotarget|November 9, 2017
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathwaysPablo Garrido, Aliaa Shalaby, Elaine M Walsh, et al.
Pageof 4